Mazor Robotics Ltd – (NASDAQ:MZOR) – Investment analysts at First Analysis issued their Q4 2018 earnings per share estimates for shares of Mazor Robotics in a research note issued to investors on Thursday, August 30th. First Analysis analyst G. Chodaczek expects that the medical instruments supplier will earn ($0.02) per share for the quarter. First Analysis also issued estimates for Mazor Robotics’ Q1 2019 earnings at $0.02 EPS and Q2 2019 earnings at $0.02 EPS.

Mazor Robotics (NASDAQ:MZOR) last announced its quarterly earnings results on Thursday, August 2nd. The medical instruments supplier reported ($0.14) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.01) by ($0.13). Mazor Robotics had a negative net margin of 12.80% and a negative return on equity of 7.17%. The firm had revenue of $13.20 million during the quarter, compared to the consensus estimate of $17.02 million. During the same quarter in the previous year, the company posted ($0.05) earnings per share. The firm’s revenue was down 14.8% on a year-over-year basis.

A number of other analysts also recently weighed in on MZOR. Needham & Company LLC restated a “sell” rating on shares of Mazor Robotics in a report on Monday, May 14th. Wells Fargo & Co increased their price objective on Mazor Robotics from $56.00 to $62.00 and gave the company a “market perform” rating in a report on Tuesday, May 15th. ValuEngine downgraded Mazor Robotics from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 10th. BidaskClub upgraded Mazor Robotics from a “sell” rating to a “hold” rating in a report on Friday, July 6th. Finally, Zacks Investment Research upgraded Mazor Robotics from a “sell” rating to a “hold” rating in a report on Wednesday. Two investment analysts have rated the stock with a sell rating, five have given a hold rating, one has issued a buy rating and one has given a strong buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $61.08.

Shares of MZOR opened at $48.35 on Friday. Mazor Robotics has a 52 week low of $41.10 and a 52 week high of $76.56. The firm has a market capitalization of $1.26 billion, a PE ratio of -96.70 and a beta of 1.56.

A number of institutional investors have recently modified their holdings of MZOR. Advisors Asset Management Inc. acquired a new stake in Mazor Robotics during the 2nd quarter worth about $451,000. Global X Management Co LLC grew its holdings in Mazor Robotics by 19.7% during the 2nd quarter. Global X Management Co LLC now owns 506,196 shares of the medical instruments supplier’s stock worth $28,099,000 after acquiring an additional 83,387 shares during the period. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management grew its holdings in Mazor Robotics by 21.9% during the 2nd quarter. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management now owns 278,119 shares of the medical instruments supplier’s stock worth $15,438,000 after acquiring an additional 50,000 shares during the period. Jane Street Group LLC grew its holdings in Mazor Robotics by 1,358.5% during the 2nd quarter. Jane Street Group LLC now owns 41,945 shares of the medical instruments supplier’s stock worth $2,317,000 after acquiring an additional 45,278 shares during the period. Finally, Dorsey Wright & Associates grew its holdings in Mazor Robotics by 35.5% during the 1st quarter. Dorsey Wright & Associates now owns 164,740 shares of the medical instruments supplier’s stock worth $9,784,000 after acquiring an additional 43,200 shares during the period. Hedge funds and other institutional investors own 26.13% of the company’s stock.

Mazor Robotics Company Profile

Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. It operates in the field of computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness and that simplifies complex surgical procedures.

Recommended Story: How to Use a Moving Average for TradingĀ 

Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.